Published in J Virol on October 01, 2004
Papillomavirus genome structure, expression, and post-transcriptional regulation. Front Biosci (2006) 2.56
The papillomavirus E2 proteins. Virology (2013) 1.30
Control of the papillomavirus early-to-late switch by differentially expressed SRp20. J Virol (2008) 1.20
Analysis of novel human papillomavirus type 16 late mRNAs in differentiated W12 cervical epithelial cells. Virology (2006) 1.17
Construction of a full transcription map of human papillomavirus type 18 during productive viral infection. J Virol (2011) 1.11
Dual effect of the SR proteins ASF/SF2, SC35 and 9G8 on HIV-1 RNA splicing and virion production. Retrovirology (2005) 1.10
The alternative splicing factor hnRNP A1 is up-regulated during virus-infected epithelial cell differentiation and binds the human papillomavirus type 16 late regulatory element. Virus Res (2007) 1.07
Acetylated Tat regulates human immunodeficiency virus type 1 splicing through its interaction with the splicing regulator p32. J Virol (2006) 1.06
HIV-1 infection induces changes in expression of cellular splicing factors that regulate alternative viral splicing and virus production in macrophages. Retrovirology (2008) 1.05
RNA splicing factors regulated by HPV16 during cervical tumour progression. J Pathol (2009) 1.04
Regulation of human papillomavirus gene expression by splicing and polyadenylation. Nat Rev Microbiol (2013) 1.04
Human papillomavirus type 16 E2 protein transcriptionally activates the promoter of a key cellular splicing factor, SF2/ASF. J Virol (2008) 1.02
A downstream polyadenylation element in human papillomavirus type 16 L2 encodes multiple GGG motifs and interacts with hnRNP H. J Virol (2005) 0.99
Productive Lifecycle of Human Papillomaviruses that Depends Upon Squamous Epithelial Differentiation. Front Microbiol (2012) 0.98
Human papillomavirus: gene expression, regulation and prospects for novel diagnostic methods and antiviral therapies. Future Microbiol (2010) 0.90
The E1circumflexE4 protein of human papillomavirus interacts with the serine-arginine-specific protein kinase SRPK1. J Virol (2007) 0.90
Human papillomavirus type 16 late gene expression is regulated by cellular RNA processing factors in response to epithelial differentiation. Biochem Soc Trans (2008) 0.88
IGF1 mRNA isoform expression in the cervix of HPV-positive women with pre-cancerous and cancer lesions. Exp Ther Med (2010) 0.83
The 3' region of human papillomavirus type 16 early mRNAs decrease expression. BMC Infect Dis (2005) 0.81
Regulation of bovine papillomavirus type 1 gene expression by RNA processing. Front Biosci (Landmark Ed) (2009) 0.80
The RNA stability regulator HuR regulates L1 protein expression in vivo in differentiating cervical epithelial cells. Virology (2008) 0.80
Human Papillomavirus E2 Regulates SRSF3 (SRp20) To Promote Capsid Protein Expression in Infected Differentiated Keratinocytes. J Virol (2016) 0.79
Control of human papillomavirus gene expression by alternative splicing. Virus Res (2016) 0.78
RNA Binding Proteins that Control Human Papillomavirus Gene Expression. Biomolecules (2015) 0.78
Splicing and Polyadenylation of Human Papillomavirus Type 16 mRNAs. Int J Mol Sci (2017) 0.75
Nip the HPV encoded evil in the cancer bud: HPV reshapes TRAILs and signaling landscapes. Cancer Cell Int (2013) 0.75
Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol (1988) 16.82
Exon recognition in vertebrate splicing. J Biol Chem (1995) 10.08
Sorting out the complexity of SR protein functions. RNA (2000) 9.25
Specific interactions between proteins implicated in splice site selection and regulated alternative splicing. Cell (1993) 8.07
Papillomavirus infections--a major cause of human cancers. Biochim Biophys Acta (1996) 7.79
Regulation of alternative splicing in vivo by overexpression of antagonistic splicing factors. Science (1994) 7.09
The essential pre-mRNA splicing factor SF2 influences 5' splice site selection by activating proximal sites. Cell (1990) 5.67
Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation. Science (1992) 4.49
Regulated tissue-specific expression of antagonistic pre-mRNA splicing factors. RNA (1998) 4.05
Phosphorylation of the ASF/SF2 RS domain affects both protein-protein and protein-RNA interactions and is necessary for splicing. Genes Dev (1997) 3.87
Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells. J Virol (1995) 3.57
Direct interaction between Sp1 and the BPV enhancer E2 protein mediates synergistic activation of transcription. Cell (1991) 3.46
U1 snRNP inhibits pre-mRNA polyadenylation through a direct interaction between U1 70K and poly(A) polymerase. Mol Cell (1998) 3.39
Properties of a non-tumorigenic human cervical keratinocyte cell line. Int J Cancer (1989) 3.30
hnRNP A/B proteins are required for inhibition of HIV-1 pre-mRNA splicing. EMBO J (1999) 3.04
The human U1A snRNP protein regulates polyadenylation via a direct interaction with poly(A) polymerase. Cell (1994) 2.70
mRNA polyadenylation and its coupling to other RNA processing reactions and to transcription. Curr Opin Cell Biol (1999) 2.51
Sequences homologous to 5' splice sites are required for the inhibitory activity of papillomavirus late 3' untranslated regions. Mol Cell Biol (1994) 2.49
Direct interaction of the U1 snRNP-A protein with the upstream efficiency element of the SV40 late polyadenylation signal. Genes Dev (1994) 2.49
Both phosphorylation and dephosphorylation of ASF/SF2 are required for pre-mRNA splicing in vitro. RNA (1997) 2.43
The carboxyl terminus of vertebrate poly(A) polymerase interacts with U2AF 65 to couple 3'-end processing and splicing. Genes Dev (2000) 2.27
Nuclear export and retention signals in the RS domain of SR proteins. Mol Cell Biol (2002) 2.04
Differentiation-linked human papillomavirus types 6 and 11 transcription in genital condylomata revealed by in situ hybridization with message-specific RNA probes. Virology (1989) 2.03
A negative regulatory element in the human papillomavirus type 16 genome acts at the level of late mRNA stability. J Virol (1991) 1.95
Human papillomavirus life cycle: active and latent phases. Semin Cancer Biol (1999) 1.88
Association with terminal exons in pre-mRNAs: a new role for the U1 snRNP? Genes Dev (1993) 1.81
Analysis of human papillomavirus type 16 late mRNA 3' processing signals in vitro and in vivo. J Virol (1990) 1.62
Epidermal organization and differentiation of HaCaT keratinocytes in organotypic coculture with human dermal fibroblasts. J Invest Dermatol (1999) 1.51
Bovine papillomavirus type 1 E2 transcriptional regulators directly bind two cellular transcription factors, TFIID and TFIIB. J Virol (1995) 1.48
The papillomavirus E2 protein: a factor with many talents. Trends Biochem Sci (1991) 1.44
A novel function for the U2AF 65 splicing factor in promoting pre-mRNA 3'-end processing. EMBO Rep (2002) 1.35
Epidermal differentiation and keratin gene expression. J Cell Sci Suppl (1993) 1.35
The human papillomavirus (HPV) 16 E2 protein induces apoptosis in the absence of other HPV proteins and via a p53-dependent pathway. J Biol Chem (2000) 1.33
cAMP response element-binding protein-binding protein binds to human papillomavirus E2 protein and activates E2-dependent transcription. J Biol Chem (2000) 1.28
Functional interaction of a novel cellular protein with the papillomavirus E2 transactivation domain. Mol Cell Biol (1997) 1.24
The human papillomavirus type 16 negative regulatory RNA element interacts with three proteins that act at different posttranscriptional levels. Proc Natl Acad Sci U S A (2000) 1.15
Identification of new poly(A) polymerase-inhibitory proteins capable of regulating pre-mRNA polyadenylation. J Mol Biol (2002) 1.14
A cellular 65-kDa protein recognizes the negative regulatory element of human papillomavirus late mRNA. Proc Natl Acad Sci U S A (1997) 1.10
HIV Rev-dependent binding of SF2/ASF to the Rev response element: possible role in Rev-mediated inhibition of HIV RNA splicing. Proc Natl Acad Sci U S A (1997) 1.06
Activity of the human papillomavirus type 16 late negative regulatory element is partly due to four weak consensus 5' splice sites that bind a U1 snRNP-like complex. J Virol (2003) 1.05
Variable expression of some "housekeeping" genes during human keratinocyte differentiation. Anal Biochem (2002) 1.03
Interaction between the HPV-16 E2 transcriptional activator and p53. Oncogene (1999) 1.02
Overexpression of essential splicing factor ASF/SF2 blocks the temporal shift in adenovirus pre-mRNA splicing and reduces virus progeny formation. J Virol (2000) 1.00
Human papillomavirus E2 down-regulates the human telomerase reverse transcriptase promoter. J Biol Chem (2002) 0.98
UVB irradiation reduces the half-life and transactivation potential of the human papillomavirus 16 E2 protein. Oncogene (2003) 0.93
Expression patterns of the human papillomavirus type 16 transcription factor E2 in low- and high-grade cervical intraepithelial neoplasia. J Pathol (1998) 0.89
Analysis of novel human papillomavirus type 16 late mRNAs in differentiated W12 cervical epithelial cells. Virology (2006) 1.17
Adenovirus 12 E4orf6 inhibits ATR activation by promoting TOPBP1 degradation. Proc Natl Acad Sci U S A (2010) 1.17
A Functional interaction between the human papillomavirus 16 transcription/replication factor E2 and the DNA damage response protein TopBP1. J Biol Chem (2002) 1.15
A novel technique with enhanced detection and quantitation of HPV-16 E1- and E2-mediated DNA replication. Virology (2003) 1.07
The alternative splicing factor hnRNP A1 is up-regulated during virus-infected epithelial cell differentiation and binds the human papillomavirus type 16 late regulatory element. Virus Res (2007) 1.07
TopBP1 regulates human papillomavirus type 16 E2 interaction with chromatin. J Virol (2007) 1.06
Activity of the human papillomavirus type 16 late negative regulatory element is partly due to four weak consensus 5' splice sites that bind a U1 snRNP-like complex. J Virol (2003) 1.05
The relationship between connexins, gap junctions, tissue architecture and tumour invasion, as studied in a novel in vitro model of HPV-16-associated cervical cancer progression. Oncogene (2003) 1.05
RNA splicing factors regulated by HPV16 during cervical tumour progression. J Pathol (2009) 1.04
Human papillomavirus type 16 E2 protein transcriptionally activates the promoter of a key cellular splicing factor, SF2/ASF. J Virol (2008) 1.02
The human papillomavirus type 31 late 3' untranslated region contains a complex bipartite negative regulatory element. J Virol (2002) 1.01
Deregulation of RNA polymerase III transcription in cervical epithelium in response to high-risk human papillomavirus. Oncogene (2005) 1.00
Nuclear relocalisation of cytoplasmic poly(A)-binding proteins PABP1 and PABP4 in response to UV irradiation reveals mRNA-dependent export of metazoan PABPs. J Cell Sci (2011) 0.96
Proline-rich tyrosine kinase 2 mediates gonadotropin-releasing hormone signaling to a specific extracellularly regulated kinase-sensitive transcriptional locus in the luteinizing hormone beta-subunit gene. Mol Endocrinol (2007) 0.95
Herpes simplex virus ICP27 protein directly interacts with the nuclear pore complex through Nup62, inhibiting host nucleocytoplasmic transport pathways. J Biol Chem (2012) 0.94
The herpes simplex virus type 1 US11 protein binds the coterminal UL12, UL13, and UL14 RNAs and regulates UL13 expression in vivo. J Virol (2002) 0.94
Characterization of a heat resistant beta-glucosidase as a new reporter in cells and mice. BMC Biol (2010) 0.94
UVB irradiation reduces the half-life and transactivation potential of the human papillomavirus 16 E2 protein. Oncogene (2003) 0.93
Human papillomavirus E1 and E2 mediated DNA replication is not arrested by DNA damage signalling. Virology (2010) 0.92
An interaction between human papillomavirus 16 E2 and TopBP1 is required for optimum viral DNA replication and episomal genome establishment. J Virol (2012) 0.91
Gaps in detailed knowledge of human papillomavirus (HPV) and the HPV vaccine among medical students in Scotland. BMC Public Health (2013) 0.90
Epstein-Barr virus induces cellular transcription factors to allow active expression of EBER genes by RNA polymerase III. J Biol Chem (2006) 0.90
TopBP1 contains a transcriptional activation domain suppressed by two adjacent BRCT domains. Biochem J (2006) 0.89
Human papillomavirus type 16 late gene expression is regulated by cellular RNA processing factors in response to epithelial differentiation. Biochem Soc Trans (2008) 0.88
Expression of TopBP1 in canine mammary neoplasia in relation to histological type, Ki67, ERalpha and p53. Vet J (2008) 0.88
Characterization of a novel wood mouse virus related to murid herpesvirus 4. J Gen Virol (2009) 0.87
Novel cellular interacting partners of the human papillomavirus 16 transcription/replication factor E2. Virus Res (2002) 0.85
Human papillomavirus 16 E2 stability and transcriptional activation is enhanced by E1 via a direct protein-protein interaction. Virology (2011) 0.85
Reduced expression of multiple gap junction proteins is a feature of cervical dysplasia. Mol Cancer (2005) 0.85
Alternative splicing in human tumour viruses: a therapeutic target? Biochem J (2012) 0.85
Human papillomavirus regulation of SR proteins. Biochem Soc Trans (2010) 0.85
P53 represses human papillomavirus type 16 DNA replication via the viral E2 protein. Virol J (2008) 0.84
The human papillomavirus 16 E2 protein is stabilised in S phase. Virology (2009) 0.84
Immunohistochemical expression of TopBP1 in feline mammary neoplasia in relation to histological grade, Ki67, ERalpha and p53. Vet J (2007) 0.84
Regulation of translation initiation by herpesviruses. Biochem Soc Trans (2008) 0.83
Effects of human papillomavirus type 16 E5 deletion mutants on epithelial morphology: functional characterization of each transmembrane domain. J Gen Virol (2009) 0.82
Fanconi anemia A is a nucleocytoplasmic shuttling molecule required for gonadotropin-releasing hormone (GnRH) transduction of the GnRH receptor. Endocrinology (2006) 0.82
A functional interaction between the MAGUK protein hDlg and the gap junction protein connexin 43 in cervical tumour cells. Biochem J (2012) 0.82
The detection of Bovine Papillomavirus type 1 DNA in flies. Virus Res (2009) 0.82
A simple, sensitive and selective quantum-dot-based western blot method for the simultaneous detection of multiple targets from cell lysates. Anal Bioanal Chem (2010) 0.81
Equine sarcoids: Bovine Papillomavirus type 1 transformed fibroblasts are sensitive to cisplatin and UVB induced apoptosis and show aberrant expression of p53. Vet Res (2012) 0.81
The fidelity of HPV16 E1/E2-mediated DNA replication. J Biol Chem (2003) 0.79
Intracellular distribution of hepatitis B virus core protein expressed in vitro depends on the sequence of the isolate and the serologic pattern. J Infect Dis (2004) 0.78
Human papillomavirus gene expression is controlled by host cell splicing factors. Biochem Soc Trans (2012) 0.77
Analysis of regulatory motifs within HPV transcripts. Methods Mol Med (2005) 0.77
Small interfering RNA targeting bovine papillomavirus type 1 E2 induces apoptosis in equine sarcoid transformed fibroblasts. Virus Res (2009) 0.77
On-chip immunoprecipitation for protein purification. Lab Chip (2010) 0.76
Assessing the detection of human papillomavirus late mRNA in liquid base cytology samples for risk stratification of cervical disease. J Med Virol (2013) 0.75
A novel two-step transcriptional activation system for gene therapy directed toward epithelial cells. Mol Cancer Ther (2009) 0.75